BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2493528)

  • 1. [Radiation therapy in brain metastases].
    Tsuchiya M; Shinozaki J; Hashida I; Kawaguchi T; Yamashita T; Kaneta K
    Gan No Rinsho; 1989 Jan; 35(1):9-14. PubMed ID: 2493528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of whole brain radiotherapy combined with fractionated stereotactic radiotherapy in metastatic brain tumors, and prognostic factors.
    Kim HJ; Hong S; Kim S; Kim JH; Chie EK; Kim IH; Park CI; Ha SW; Wu HG; Kim DG; Kang WS
    Radiat Med; 2003; 21(4):155-60. PubMed ID: 14514121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
    Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation therapy of brain metastases].
    Hata K
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1017-21. PubMed ID: 6471404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival after brain metastases in breast cancer.
    Kocher M; Müller RP; Staar S; Degroot D
    Strahlenther Onkol; 1995 May; 171(5):290-5. PubMed ID: 7770785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of radiotherapy in brain metastasis].
    Schultze J; Kaya A; Kimmig B
    Rontgenpraxis; 2000; 53(3):102-9. PubMed ID: 11131110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CNS metastases in malignant melanomas].
    Willner J; Bohndorf W
    Strahlenther Onkol; 1995 Mar; 171(3):165-73. PubMed ID: 7709333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of solitary brain metastasis. Resection followed by whole brain radiation therapy (WBRT) and a radiation boost to the metastatic site.
    Rades D; Raabe A; Bajrovic A; Alberti W
    Strahlenther Onkol; 2004 Mar; 180(3):144-7. PubMed ID: 14991201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy for cerebral metastases.
    Sneed PK; Larson DA; Wara WM
    Neurosurg Clin N Am; 1996 Jul; 7(3):505-15. PubMed ID: 8823778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical research of radiotherapy in brain metastasis].
    Okawa T; Kita M; Nishijima H; Miyaji N; Akita U; Tsuchiya M; Kaneta K; Nakama M; Sugawara T
    Gan No Rinsho; 1988 Aug; 34(9):1139-46. PubMed ID: 3172519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of overall treatment time in patients irradiated for more than three brain metastases.
    Rades D; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Dunst J; Schild SE
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1509-13. PubMed ID: 17689033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic factors for the radiation treatment of the cerebral metastases from breast carcinoma].
    Busetto M; Polico R; Antonello M; Conte G; Masato M; Ravenna C; Bruscagnin A
    Radiol Med; 1991 Nov; 82(5):652-7. PubMed ID: 1780465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases.
    Rades D; Haatanen T; Schild SE; Dunst J
    Cancer; 2007 Sep; 110(6):1345-50. PubMed ID: 17639588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.